IN2014DE00037A - - Google Patents

Info

Publication number
IN2014DE00037A
IN2014DE00037A IN37DE2014A IN2014DE00037A IN 2014DE00037 A IN2014DE00037 A IN 2014DE00037A IN 37DE2014 A IN37DE2014 A IN 37DE2014A IN 2014DE00037 A IN2014DE00037 A IN 2014DE00037A
Authority
IN
India
Prior art keywords
drug
containing particle
coating composition
particle
preparing
Prior art date
Application number
Other languages
English (en)
Inventor
Takuya Yokosawa
Yuichi Nishiyama
Naosuke Maruyama
Original Assignee
Shinetsu Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49885183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DE00037(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shinetsu Chemical Co filed Critical Shinetsu Chemical Co
Publication of IN2014DE00037A publication Critical patent/IN2014DE00037A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/32—Cellulose ether-esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paints Or Removers (AREA)
IN37DE2014 2013-01-11 2014-01-06 IN2014DE00037A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013003534A JP5836980B2 (ja) 2013-01-11 2013-01-11 薬物含有粒子、固形製剤及び薬物含有粒子の製造方法

Publications (1)

Publication Number Publication Date
IN2014DE00037A true IN2014DE00037A (enExample) 2015-05-08

Family

ID=49885183

Family Applications (1)

Application Number Title Priority Date Filing Date
IN37DE2014 IN2014DE00037A (enExample) 2013-01-11 2014-01-06

Country Status (6)

Country Link
US (1) US11052051B2 (enExample)
EP (1) EP2754438B2 (enExample)
JP (1) JP5836980B2 (enExample)
KR (1) KR101911977B1 (enExample)
CN (1) CN103920159B (enExample)
IN (1) IN2014DE00037A (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6203702B2 (ja) * 2014-11-18 2017-09-27 信越化学工業株式会社 ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法
EP3216807B2 (en) 2016-03-09 2022-05-18 Shin-Etsu Chemical Co., Ltd. Coating composition containing methyl cellulose, method for producing the same, and solid preparation
JP2018141239A (ja) 2017-02-28 2018-09-13 Ｄｏｗａエレクトロニクス株式会社 銀ナノワイヤインク
WO2020218310A1 (ja) * 2019-04-22 2020-10-29 ニプロ株式会社 医薬製剤の製造方法
JP7165626B2 (ja) * 2019-06-06 2022-11-04 信越化学工業株式会社 インクジェット印刷を行う錠剤向けのコーティング用組成物、これを用いた水性インクによる印字を有する錠剤及びその製造方法
JP7399060B2 (ja) * 2020-10-01 2023-12-15 信越化学工業株式会社 ヒドロキシプロピルメチルセルロースアセテートサクシネートの製造方法
JP7399061B2 (ja) * 2020-10-01 2023-12-15 信越化学工業株式会社 ヒドロキシプロピルメチルセルロースフタレートの製造方法
WO2025187709A1 (ja) * 2024-03-08 2025-09-12 キャプシュゲル・ベルジウム・エヌ・ヴィ 可食性インク組成物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1166777A (en) * 1915-02-09 1916-01-04 Revere Rubber Co Process of vulcanizing rubber, rubber-like, or similar materials.
US2510923A (en) * 1945-03-03 1950-06-06 Gen Mills Inc Recording sound on wire
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
JP2916978B2 (ja) 1993-08-25 1999-07-05 エスエス製薬株式会社 放出開始制御型製剤
US5733575A (en) 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
JPH08245423A (ja) * 1995-03-06 1996-09-24 Shionogi & Co Ltd 水系腸溶性コーティング液
JP4263776B2 (ja) * 1996-08-09 2009-05-13 杏林製薬株式会社 イブジラストの徐放化経口錠剤およびその製造方法
EP1027887B1 (en) 1999-02-10 2008-08-13 Pfizer Products Inc. Matrix controlled release device
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
US20030175350A1 (en) 2000-07-11 2003-09-18 Katsuji Sugita Enteric preparations containing physiologically active peptides
JP2004532257A (ja) * 2001-05-31 2004-10-21 シーマ・ラブス、インコーポレイテッド 高水溶性薬剤のテイスト・マスキング
JP2004067606A (ja) * 2002-08-08 2004-03-04 Zensei Yakuhin Kogyo Kk イトラコナゾール経口投与製剤
AU2003284942A1 (en) * 2002-10-30 2004-06-07 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US7294347B2 (en) * 2004-06-21 2007-11-13 Council Of Scientific And Industrial Research Coating compositions for bitterness inhibition
JP2007031407A (ja) * 2005-07-29 2007-02-08 Shin Etsu Chem Co Ltd 低置換度セルロースエーテル含有コーティング用組成物及び不快な味が隠蔽されたフィルムコーティング製剤
JP4439499B2 (ja) 2005-08-01 2010-03-24 大日本住友製薬株式会社 アムロジピン含有粒子およびそれからなる口腔内崩壊錠
JP5405752B2 (ja) 2007-01-31 2014-02-05 大日本住友製薬株式会社 被覆された薬物含有粒子および該粒子を含む固形製剤
WO2009132208A1 (en) 2008-04-24 2009-10-29 Evestra, Inc. Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
KR101705204B1 (ko) 2009-09-11 2017-02-09 롯데정밀화학 주식회사 장용성 경질 캡슐용 수성 조성물, 장용성 경질 캡슐의 제조방법 및 장용성 경질 캡슐
KR101182827B1 (ko) 2010-06-11 2012-09-14 삼성정밀화학 주식회사 장용성 경질 캡슐의 제조방법 및 장용성 경질 캡슐
WO2012029838A1 (ja) 2010-08-31 2012-03-08 協和発酵キリン株式会社 口腔内崩壊錠
JP4803686B2 (ja) 2010-08-31 2011-10-26 協和発酵キリン株式会社 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠
US20120251588A1 (en) * 2011-03-30 2012-10-04 Miyuki Fukasawa Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation

Also Published As

Publication number Publication date
EP2754438B2 (en) 2020-08-05
JP2014133722A (ja) 2014-07-24
KR20140091475A (ko) 2014-07-21
EP2754438B1 (en) 2017-03-08
CN103920159A (zh) 2014-07-16
EP2754438A1 (en) 2014-07-16
CN103920159B (zh) 2018-01-16
JP5836980B2 (ja) 2015-12-24
KR101911977B1 (ko) 2018-10-25
US11052051B2 (en) 2021-07-06
US20140199406A1 (en) 2014-07-17

Similar Documents

Publication Publication Date Title
IN2014DE00037A (enExample)
CY1123937T1 (el) Σκευασμα ξηρης σκονης που περιλαμβανει ενα αντιχολινεργικο, ενα κορτικοστεροειδες και ενα βητα-αδρενεργικο για χορηγηση δια εισπνοης
PH12014501446A1 (en) Solid nicotine-comprising dosage form with reduced organoleptic disturbance
IL223795A (en) History of Tetrahydro-Pyrido-Pyrimidine
IL221160A (en) 4,2,1-triazine-3-amine derivatives, a process for their preparation and use for drug preparation
HUE039931T2 (hu) Szfingozin-1-foszfát receptor agonisták, azok elkészítési eljárásai, és azokat aktív ágensként tartalmazó gyógyszerészeti készítmények
MX363347B (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
AU2013373885B2 (en) Oxazolidone compound, preparing method and application thereof
EP4360626A3 (en) Use of stearate in an inhalable formulation
GB201200192D0 (en) Methotrexate composition
PL3641730T3 (pl) Cząstka i kompozycja farmaceutyczna zawierająca nierozpuszczalną pochodną kamptotecyny z podwójną strukturą rdzenia i powłoki oraz sposób ich wytwarzania
WO2014041565A3 (en) Improved process for preparation of vilanterol and intermediates thereof
IL222578A0 (en) Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
EP2323757A4 (en) STABLE SILVER-BASED STABLE COLLOIDS AND SILVER-COATED SILVER-BASED COLLOIDS, AND PROCESSES FOR PREPARING THE SAME
MX2021004439A (es) Formulacion solida oral que contiene irinotecan y metodo de preparacion de la misma.
IN2012DE00868A (enExample)
EP4233874A3 (en) Acetylsalicylic acid for reducing the risk of a thromboembolic event
ZA202210822B (en) Preparation of solid dosage forms comprising antibodies by solution/suspension layering
IL268458A (en) Nicotine inhalable formulations and methods of making and using them
WO2011037976A3 (en) Pramipexole pharmaceutical formulations
IL291953A (en) Formulations of non-animal soft gel capsules, methods of preparation and methods of use thereof
MX2013009703A (es) Precombinaciones de sabores para goma de mascar, metodos para elaborar precombinaciones de sabores, y composiciones de goma de mascar de las mismas.
EP3615011A4 (en) PHARMACEUTICAL COMPOSITION FOR IN VIVO ADMINISTRATION, PROCESS FOR THE PREPARATION OF A PHARMACOLOGICALLY ACTIVE PRINCIPLE SENSITIVELY INSOLUBLE IN WATER
IL213671A (en) Pharmaceutical preparations containing alglitazar, a process for their preparation and use for the preparation of medicines
PH12016500693B1 (en) Slow-release solid oral compositions